feed,title,long_url,short_url
MarketWatch,Novavax's experimental COVID-19 shot has 86.4% efficacy against the Alpha variant,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/O_dRX1asn2E/story.aspx,https://on.mktw.net/3x6pu34
